Status | Study |
RECRUITING |
Study Name: Mindfulness in Hidradenitis Suppurativa Condition: Hidradenitis Suppurativa Date: 2023-10-03 Interventions: The MBSR course will consist of weekly sessions lasting two and a half hours, involving lecture, meditation, and self-reflection.Mindfulness |
RECRUITING |
Study Name: A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Condition: Hidradenitis Suppurativa Date: 2023-09-14 Interventions: Administered SC |
RECRUITING |
Study Name: Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa Condition: Hidradenitis Suppurativa Date: 2023-09-11 Interventions: Patients receive 2 capsules daily for one week followed by one capsule daily for 2 weeks.MTT capsules are derived from a single donor per patien |
RECRUITING |
Study Name: A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Condition: Hidradenitis Suppurativa Date: 2023-08-31 Interventions: Oral Tablet |
RECRUITING |
Study Name: Physical Activity in Hidradenitis Suppurativa (HS) Condition: Hidradenitis Suppurativa Date: 2023-08-23 Interventions: Participants will perform a minimum of one exercise from each of the targeted muscle groups at a frequency of every other day, for a total of 3-4 days |
RECRUITING |
Study Name: Evaluating the Safety and Efficacy of Deucravacitinib Compared to Placebo Hidradenitis Suppurativa (HS). Condition: Hidradenitis Suppurativa Date: 2023-08-10 Interventions: Deucravacitinib is a stable deuterium-containing compound (where deuterium is a stable, nonradioactive isotope of hydrogen) and a potent, highly selec |
RECRUITING |
Study Name: Hidradenitis Suppurativa Study of Izokibep Condition: Date: 2023-06-07 Interventions: Form: Solution for injectionRoute of administration: Subcutaneous (SC) |
RECRUITING |
Study Name: Hidradenitis Suppurativa Study of Izokibep Condition: Hidradenitis Suppurativa Date: 2023-06-07 Interventions: Form: Solution for injectionRoute of administration: Subcutaneous (SC) |
RECRUITING |
Study Name: A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy Condition: Hidradenitis Suppurativa Date: 2023-05-26 Interventions: Oral Tablets |
RECRUITING |
Study Name: A Study to Test the Efficacy and Safety of SAR442970 in Adults With Hidradenitis Suppurativa Condition: Hidradenitis Suppurativa Date: 2023-04-28 Interventions: 1 mL extractable volume of 150 mg/mL SAR442970 filled in 2 mL glass vial |